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Background
Human immunodeficiency virus (HIV) is infecting over
34.0 million people worldwide, being responsible for one
of the major current pandemics [1]. The most severely
affected region is the Sub-Saharan Africa where nearly 1
in 20 adults is infected with HIV, accounting for 69% of
infections worldwide [1]. Several strategies to halt HIV
spread are currently being pursued, including the use of
ectopic microbiocides. This approach is particularly
important for women, among which the infection rate
can be almost three more times than men. Cyanovirin-
N (CVN) is a lectin-like protein isolated from blue algae
Nostoc ellipsosporum. CVN is highly thermo stable and
is capable of binding to HIV GP120 protein blocking
viral infection [2,3]. In this report we describe the use of
transgenic soybean plants as a potential platform to
achieve large scale, cost-effective production of CVN.
Methods
The fragment of 306bp corresponding to CVN coding
region was amplified by PCR from pET30b-CVN (BioSyn)
vector and cloned into bombardment vector pbCong. This
vector contains the promoter and the complete signal pep-
tide of the soybean b-conglycinin gene with a CaMV35S
terminator. The final vectors pbCongCVN and pAC321
(containing Imazapyr herbicide resistance gene) were co-
bombarded in a 1:1 ratio into the apical meristem of
somatic embryonic axes from mature soybean seeds cv.
BR-16, utilizing a particle bombardment device [4]. Trans-
genic R0 plants were cultivated under green-house condi-
tions to produce seed. R1 seeds were analyzed by PCR
and ELISA-gp120 followed by nanoUPLC-MSE [5] to
characterize and quantify the expression levels of recombi-
nant CVN. Seeds were grinded and proteins were
extracted using 50mM Tris-HCl pH 8.0 in 1:20 (w:v) ratio.
Total soluble proteins (TSP) were separated using gel fil-
tration sephadex s200 followed by HPLC C4 reversed
phase. Fraction containing semi-purified recombinant
CVN were used for anti-HIV assay.
Results and conclusions
From 1.000 embryonic axes used in bombardment, 20
plants were recovered from herbicide selection and only
8 contained CVN transgene. After ELISA-gp120 two
plants showed CVN binding to gp120 HIV glicoprotein.
NanoUPLC-MSE results from TSP indicates a expres-
sion level of 1.5%. Structure characterization showed
correct sequence which was possibly glycosilated. Anti-
HIV assays from semi-purified SOY-CVN indicates
microbicidal activity that was 10 folds less effective than
the CVN control produced in Escherichia coli. Mass
spectrometry quantification of this fraction confirms
10 fold dilution with other soybean seeds proteins, pos-
sibly due to a high affinity binding of CVN for glycinin
and b-conglycinin which are abundant in soybean seeds.
Therefore, production of pure recombinant CVN from
soybean seeds is currently being optimized, and may
contribute the development of an important HIV infection
prevention method.
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